In the total patient population, 5.7% had a potentially prolactin-related adverse effect (prolactin elevation, amenorrhea/menstrual irregularity in female patients, galactorrhea, gynecomastia, erectile dysfunction, and decreased general sexual function in males) which greatly affected compliance to treatment [67,68,70,75,78,84]. Here, PRL is linked to Gynecomastia.